The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT-Reference-Cited by-同舟云学术

The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT

Published:2023-03-28 Issue:6 Volume:58 Page:621-624
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tournilhac Olivier^ORCID,van Gelder Michel,Eikema Dirk-Jan,Zinger Nienke,Dreger Peter^ORCID,Bornhäuser Martin,Vucinic Vladan^ORCID,Scheid Christof,Cornelissen Jan J.,Schroeder Thomas,Jindra Pavel^ORCID,Sengeloev Henrik,Nguyen Quoc Stephanie,Stelljes Matthias,Blau Igor Wolfgang,Mayer Jiri,Paneesha Shankara,Chevallier Patrice^ORCID,Forcade Edouard^ORCID,Kröger Nicolaus^ORCID,Blaise Didier^ORCID,Gribben John^ORCID,Nielsen Bendt,Johansson Jan-Erik,Kyriakou Charalampia,Beguin Yves,Pioltelli Pietro,Sampol Antònia^ORCID,McLornan Donal P.^ORCID,Schetelig Johannes,Hayden Patrick J.^ORCID,Yakoub-Agha Ibrahim^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-01955-z.pdf

Reference17 articles.

1. van Gelder M, Ziagkos D, de Wreede L, van Biezen A, Dreger P, Gramatzki M, et al. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia—A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT. Clin Lymphoma Myeloma Leuk. 2017;17:667–5.e2.

2. Krämer I, Stilgenbauer S, Dietrich S, Böttcher S, Zeis M, Stadler M, et al. Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood. 2017;130:1477–80.

3. Tournilhac O, Garff-Tavernier ML, Quoc SN, Forcade E, Chevallier P, Legrand-Izadifar F, et al. Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial. Haematologica. 2021;106:1867–75.

4. Kharfan-Dabaja MA, El-Asmar J, Awan FT, Hamadani M, Ayala E. Current state of hematopoietic cell transplantation in CLL as smart therapies emerge. Best Pract Res Clin Haematol. 2016;29:54–66.

5. Hallek M, Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021;96:1679–705.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

2. Chronic lymphocytic leukaemia;The Lancet;2024-08

3. Modern approach to the treatment of chronic lymphocytic leukemia;Onkologie;2023-10-05